Lo: How Should Vaccines Be Financed?
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
Thriving Together: Health Equity and the Social Determinants of Health; Seminar with Peter Eckart
The Camden (NJ) Coalition’s influential care management program—which targeted high-use, high-need patients —did not reduce hospital readmissions, but did improve intermediate care coordination
This convening introduced the HSI Lab on Employee Population Health
As the health care industry moves toward value-based care, there are increasingly diverse publicly accessible hospital quality metrics. But which are significant? Joseph Doyle tests these measures.
Charles Senteio is one of MIT’s MLK Scholars. His community-based health informatics research focuses on addressing health inequities, by examining how perceptions influence behavior and outcomes
On February 23, 2024, The MIT Sloan Healthcare Club convened the 22nd annual MIT Sloan Healthcare and Bioinnovations Conference.
The U.S. deceased-donor organ allocation system faces significant inefficiencies, including inequitable access, disparities among patients, low organ utilization, and high patient mortality.
Overview of the Medicine for Managers course developed by Prof. Richard Cohen, one of the classes offered as part of the MIT Healthcare Certificate
Gaye Bok, an MIT Sloan alum, heads up the Mass General Brigham’s (MGB) $30M AI and Digital Innovation Venture Fund (AIDIF).